DE69328308D1 - Wundverbände - Google Patents

Wundverbände

Info

Publication number
DE69328308D1
DE69328308D1 DE69328308T DE69328308T DE69328308D1 DE 69328308 D1 DE69328308 D1 DE 69328308D1 DE 69328308 T DE69328308 T DE 69328308T DE 69328308 T DE69328308 T DE 69328308T DE 69328308 D1 DE69328308 D1 DE 69328308D1
Authority
DE
Germany
Prior art keywords
pct
chemically modified
modified polymer
date jun
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69328308T
Other languages
English (en)
Inventor
Michael Fowler
Richard Burrow
Dudley Turner
Jan Schmidt
Lip Yong Chung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College Cardiff Consultants Ltd
Cardiff University
Original Assignee
University College Cardiff Consultants Ltd
Cardiff University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College Cardiff Consultants Ltd, Cardiff University filed Critical University College Cardiff Consultants Ltd
Application granted granted Critical
Publication of DE69328308D1 publication Critical patent/DE69328308D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Surgical Instruments (AREA)
DE69328308T 1992-12-08 1993-12-03 Wundverbände Expired - Lifetime DE69328308D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929225581A GB9225581D0 (en) 1992-12-08 1992-12-08 Wound dressings
PCT/GB1993/002490 WO1994013333A1 (en) 1992-12-08 1993-12-03 Wound dressings

Publications (1)

Publication Number Publication Date
DE69328308D1 true DE69328308D1 (de) 2000-05-11

Family

ID=10726264

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328308T Expired - Lifetime DE69328308D1 (de) 1992-12-08 1993-12-03 Wundverbände

Country Status (9)

Country Link
US (1) US5667501A (de)
EP (1) EP0673262B1 (de)
JP (1) JPH08503869A (de)
AT (1) ATE191348T1 (de)
AU (1) AU679954B2 (de)
CA (1) CA2151246C (de)
DE (1) DE69328308D1 (de)
GB (2) GB9225581D0 (de)
WO (1) WO1994013333A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612321A (en) † 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
US5861149A (en) * 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US6699672B1 (en) * 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20030161823A1 (en) * 1998-08-31 2003-08-28 Neta Ilan Therapeutic and cosmetic uses of heparanases
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
EP1041970B1 (de) * 1998-10-23 2013-07-03 Polyheal Ltd. Zusammensetzungen von mikrosphaeren zur wundheilung
AU1617800A (en) * 1998-11-12 2000-05-29 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
EP1157118A4 (de) * 1999-03-01 2002-07-17 Insight Strategy & Marketing POLYNUKLEOTID, DAS FüR EIN POLYPEPTID MIT HEPARANASE-AKTIVäT KODIERT, UND DESSEN EXPRESSION IN GENETISCH VERäNDERTEN ZELLEN
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
DE60142632D1 (de) 2000-11-30 2010-09-02 Novodermix Internat Ltd Heilung von wunden
GB0107653D0 (en) * 2001-03-27 2001-05-16 Bristol Myers Squibb Co Wound dressing
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
US7101862B2 (en) * 2001-12-31 2006-09-05 Area Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
GB2386899B (en) * 2002-03-25 2005-10-26 Johnson & Johnson Medical Ltd Wound dressings comprising chemically modified polysaccharides
GB2386900B (en) * 2002-03-25 2006-11-01 Johnson & Johnson Medical Ltd Use in wound dressings of chemically modified polysaccharides
WO2004064881A1 (en) * 2003-01-24 2004-08-05 Insense Limited Skin treatment formulations
US20060142684A1 (en) * 2003-04-11 2006-06-29 Shanbrom Technologies, Llc Oxygen releasing material
US20060269552A1 (en) * 2003-06-09 2006-11-30 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
GB2408206B (en) 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
US20060159732A1 (en) * 2003-06-20 2006-07-20 Cullen Breda M Antioxidant wound dressing materials
GB2408207A (en) 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
US20050281890A1 (en) * 2004-06-18 2005-12-22 San Chandan K Methods and compositions for wound healing
US7485619B2 (en) 2005-01-31 2009-02-03 Yeon Sook KIM Antimicrobial agent
FR2882595B1 (fr) * 2005-02-25 2007-05-25 Oreal Procede pour evaluer le potentiel de desactivation de radicaux libres de la peau
US8084268B2 (en) * 2005-02-25 2011-12-27 L'oreal Method of evaluating the potential of the skin for scavenging free radicals
ITMI20050881A1 (it) * 2005-05-16 2006-11-17 Anna Favre Kit diagnostico per la malattia di hirschsprung megalon congenito
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
US8852558B2 (en) * 2008-03-11 2014-10-07 Materials Modification, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
US8828358B2 (en) * 2008-03-11 2014-09-09 Materials Modifications, Inc. In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
US8529528B2 (en) * 2008-12-24 2013-09-10 Kci Licensing, Inc. Reduced-pressure wound treatment systems and methods employing microstrain-inducing manifolds
US8486032B2 (en) * 2008-12-24 2013-07-16 Kci Licensing, Inc. Reduced-pressure treatment systems and methods employing debridement mechanisms
US8708984B2 (en) * 2008-12-24 2014-04-29 Kci Licensing, Inc. Reduced-pressure wound treatment systems and methods employing manifold structures
EP2741788A4 (de) 2011-08-14 2015-03-25 Materials Modification Inc Verfahren und zusammensetzung zur in-situ-bildung einer künstlichen sperre zur bekämpfung von blutverlust
CA2888241C (en) 2012-10-16 2020-12-29 Surmodics, Inc. Wound packing device and methods
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
KR20200060997A (ko) 2018-11-23 2020-06-02 (주)메디코스바이오텍 창상치료용 약학조성물
CN115381735A (zh) * 2022-08-13 2022-11-25 上海纳米技术及应用国家工程研究中心有限公司 一种用于皮肤抗氧化的水凝胶敷料及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4781921A (en) * 1986-10-06 1988-11-01 The University Of Akron Hydrogels of quadrol methacrylate polymers
JPS63207832A (ja) * 1987-02-24 1988-08-29 Asahi Chem Ind Co Ltd ポリアセタ−ル樹脂の接着性改良方法
FR2638972B1 (fr) * 1988-11-14 1990-12-14 Osteal Medical Laboratoires Ciment pour la fixation de protheses osseuses

Also Published As

Publication number Publication date
GB2288736B (en) 1996-10-02
ATE191348T1 (de) 2000-04-15
AU5654694A (en) 1994-07-04
JPH08503869A (ja) 1996-04-30
CA2151246A1 (en) 1994-06-23
CA2151246C (en) 2006-10-03
US5667501A (en) 1997-09-16
WO1994013333A1 (en) 1994-06-23
AU679954B2 (en) 1997-07-17
GB2288736A (en) 1995-11-01
EP0673262A1 (de) 1995-09-27
EP0673262B1 (de) 2000-04-05
GB9225581D0 (en) 1993-01-27
GB9511571D0 (en) 1995-09-06

Similar Documents

Publication Publication Date Title
DE69328308D1 (de) Wundverbände
FI953490A (fi) Kuidut
DE60008790D1 (de) Medizinische verbände enthaltend gelartiger honig
DE69130320T2 (de) Katalysator für alpha-olefinpolymerisation und herstellung von poly(alpha)olefinen damit
ATE221358T1 (de) Verbandssystem
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
CA2237606A1 (en) Portable wound treatment apparatus
DK4893D0 (da) Hudpladeprodukt
DE69326418T2 (de) Medizinisch, hochwasserabsorbierende Polymere für Wundverbände und medizinische Binden
NO984467L (no) FremgangsmÕte for l°sningspolymerisasjon med dispergert katalytisk aktivator
MY119039A (en) Stabilization of a polymer
DE69409102D1 (de) Wundverband
ATE193443T1 (de) Verwendung eines imidazols zur herstellung eines medikamentes zur behandlung der arteriosklerose
TR199801365T2 (xx) �yile�me s�recinin kontrol�.
MX9700959A (es) Derivados de becimidazol que tienen actividad dopaminergica.
ATE186457T1 (de) Heftpflaster für intravenöse katheter
BR9806869A (pt) Processos para reduzir a taxa de reação do processo de polimerização pela adição de um desativador de catalisador e para a inativar um processo de reator.
DE69600367D1 (de) Verwendung von Sulfasalazin und/oder dessen aktiven Metaboliten zur Herstellung eines Arzneimittels zur Behandlung von venöser Insuffizienz und venösen Ulcera
DE69623325T2 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
Deas et al. The toxicity of commonly used antiseptics on fibroblasts in tissue culture
SE9603284D0 (sv) New compounds
ATE234110T1 (de) Komponente b als wundheilendes mittel
DE69428276T2 (de) Insulinähnlicher wachstumfaktor ii als antitumormittel
ATE329609T1 (de) Peptide zur behandlung von wundkontraktion
ATE253945T1 (de) Verwendung von wundverbänden zur behandlung von akuten wunden

Legal Events

Date Code Title Description
8332 No legal effect for de